Lawmakers look to repeal medical device tax

 

Momentum is building in Congress to repeal the medical device tax.

A group of bipartisan lawmakers are working to repeal the 2.3 percent tax on medical device sales, which was instituted as part of the Affordable Care Act, according to several news sources.

They are backing legislation sponsored by Rep. Erik Paulson (R-Minn.), the Protect Medical Innovation Act. According to Paulsen, the device tax has resulted in the loss of more than 33,000 jobs and future losses are estimated at 132,000. “The medical device tax continues to eliminate thousands of good-paying jobs and stifle medical innovation,” he said in a statement.

Paulsen’s legislation not only eliminates the tax but would refund companies for taxes already paid.

To date, the bill has support from well over half the House, including two dozen Democrats. However, they face obstacles if they are unable to find the money elsewhere to offset the revenue lost from repeal. The tax is expected to raise nearly $30 billion over a decade, reports The Hill.

 

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.